About the project

 

V.A. Cure is a European MSCA-ITN network aiming to uncover core mechanisms of initiation and maintenance of Vascular Anomalies (VAs) and to leverage this information for establishing novel therapeutic strategies. The network consortium consists of 7 academic laboratories and 2 companies from across Europe, and is supported by 9 partner organisations.
The 14 Early Stage Researchers (ESRs) will be a part of  the unique international PhD program, consisting of an individual research project, the network’s training programme, intersectoral secondments and outreach activities. Project goal is to  ensure a comprehensive perception of the research and drug/technology development in pharma industry/biotech and academia.

News

  • European Research Night 2020

    Due to Covid-19, European Research Night was organized as a series of virtual events all across Europe. Scientists prepared presentations with interaction with the audience, descriptive videos and live experiments. Five students from our network participated in these events. Martina De Bortoli and Murat Alpaslan from De Duve Institute prepared a video describing their research

  • Discovery of a novel gene involved in primary lymphedema

    The Human Molecular Genetics laboratory of the de Duve Institute (UCLouvain), headed by Professor Miikka Vikkula, has identified a novel gene responsible for a lymphatic disease called primary lymphedema. Together with the group of Professor Kari Alitalo in Finland, they identified mutations that alter the function of a protein that is known to play a

  • New effective way to inhibit lymphatic malformations

    Lymphatic malformation is a debilitating and often incurable disease. Taija Mäkinen’s research group has in an international collaboration studied cellular mechanisms leading to abnormal vessel growth and identified a combination therapy that may allow effective treatment of these malformations. Lymphatic malformations are often congenital vascular anomalies that are characterised by abnormal vessel growth. These malformations

V.A. Cure
@VACure1



We are closing our #studentpitchmonth with the presentation of the innovative work of our #PhDstudent @TuanNguyen_FA at start-up company @Finnadvance!
Check his 📽️👉 https://t.co/GMgyVrRTPV and share with us what you think! @MSCActions #H2020 #research #Science

View on Twitter

2

4

Follow us on Facebook

Project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 814316